结果显示，该研究达到了主要终点和次要终点。与安慰剂相比，Gardasil 9可降低9种HPV相关肛门生殖器持续感染的综合发生率。 默沙东宣布九价HPV疫苗 ...

病毒样颗粒（virus-like particles, VLPs）在过去的二十年中引起了人们的广泛关注。截至目前，VLP疫苗已被获批用于预防三种传染性病原体——乙型肝炎病毒（HBV）、人乳头瘤病毒（HPV）和戊型肝炎病毒 ...

GARDASIL 9 is a vaccine that helps protect against disease caused by the following types of Human Papillomavirus (HPV): 6, 11, 16, 18, 31, 33, 45, 52 and 58. For more information, see Section 1.

依托 VLP 技术，康希诺引领中国疫苗创新2024 年 10 月 9 日，康希诺生物股份公司发布了关于签署重组脊髓灰质炎（VLP-Polio）疫苗及相关联合疫苗项目资助协议的公告。依据此次签署的协议，康希诺将获得盖茨基金会提供的总计超过 1700 ...

In its rush to market its human papillomavirus vaccine, Merck forgot to make a strong and compelling case for compulsory immunization. Merck's human papillomavirus (HPV) vaccine Gardasil should ...

COMPARED to most head and neck malignancies, the rate of throat cancer in the United States and around the globe has not declined. The statistics are also true, when extrapolated, for other countries, ...

Drug company Merck & Co. is on trial for its Gardasil vaccine, used to treat human papillomavirus (HPV). Plaintiffs suing Merck claim that the vaccine caused serious health conditions, and that ...

新泽西州拉威市 - 默沙东集团（NYSE: MRK）宣布其21价肺炎球菌结合疫苗CAPVAXIVE在IDWeek 2024上公布的STRIDE-8三期临床试验结果积极。该研究将CAPVAXIVE与现有疫苗进行比较，结果显示它对所有21种血清型都具有免疫原性，并在慢性病成年人中表现出良好的安全性。 根据疾控中心2018-2021年的数据，CAPVAXIVE针对的血清型约占50岁及以上成年人侵袭性肺炎 ...

That's the question millions of parents face as television ads push for girls to receive Gardasil, a vaccine that prevents infection from four types of human papilloma virus (HPV)—the most ...

Gardasil was not the first example of a higher-priced, hard-to-manufacture vaccine proving its medical and commercial worth: Jansen points to Prevnar (diphtheria CRM197 protein), Wyeth's vaccine ...

周二，Truist Securities调整了制药巨头默沙东集团 (NYSE:MRK)的股票目标价，从之前的143.00美元下调至132.00美元。尽管目标价下调，该公司仍维持对该股票的买入评级。

We recently compiled a list of the 8 Best US Stocks For Foreign Investors Right Now. In this article, we are going to take a ...